Reloxa Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Rabeprazole Na

Indications/Uses

Active duodenal ulcer; benign gastric ulcer. Erosive or ulcerative GERD. Eradication of H. pylori-+ve duodenal ulcers.

Click to view Reloxa detailed prescribing information

Dosage/Direction for Use

Adult & elderly Severe erosive or ulcerative GERD 20 mg once daily for 4-8 wk. Maintenance: 10-20 mg daily depending on response. Symptomatic disease w/ or w/o erosive or ulcerative oesophagitis 10-20 mg once daily for 4 wk. Active PUD 20 mg daily, 4-8 wk for duodenal ulcer & 6-12 wk for gastric ulcer. Eradication of H. pylori 20 mg bid + clarithromycin 250 mg bid + metronidazole 400 mg bid for 1 wk. Zollinger-Ellison syndrome 60 mg once daily or up to 100-120 mg daily in 2 divided doses.

Click to view Reloxa detailed prescribing information

Overdosage

View Reloxa overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity. Pregnancy & lactation.

Click to view Reloxa detailed prescribing information

Special Precautions

Patients w/ severe hepatic dysfunction. Not recommended in childn.

Click to view Reloxa detailed prescribing information

Adverse Reactions

Headache, diarrhea & nausea.

Click to view Reloxa detailed prescribing information

Drug Interactions

Decreased ketoconazole levels; increased in digoxin levels.

Click to view Reloxa detailed prescribing information

Storage

View Reloxa storage conditions for details to ensure optimal shelf-life.

Description

View Reloxa description for details of the chemical structure and excipients (inactive components).

Action

View Reloxa mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antacids, Antireflux Agents & Antiulcerants

ATC Classification

A02BC04 - rabeprazole ; Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

Regulatory Classification

Presentation/Packing

Form

Reloxa EC tab 20 mg

Packing/Price

30's

Form

Reloxa lyo powd for IV inj 20 mg

Packing/Price

((+ 5 mL amp diluent)) 10 mL x 1's

Reloxa

rabeprazole

Manufacturer:

Ravian Life Sciences

Distributor:

Cathay Drug